|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | - |
| 31/10/25 | Yield10 Bioscience, Inc. Went Out of Business | CI |
| 14/10/25 | First Amended Joint Liquidation Plan Approved for Yield10 Bioscience, Inc. | CI |
| Capitalization | 229K 198K 178K 171K 312K 21.06M 327K 2.11M 845K 10.1M 860K 842K 36.12M | P/E ratio 2022 |
-0.6x | P/E ratio 2023 | -0.13x |
|---|---|---|---|---|---|
| Enterprise value | 2.34M 2.02M 1.82M 1.75M 3.19M 215M 3.33M 21.52M 8.62M 103M 8.78M 8.59M 369M | EV / Sales 2022 |
14.6x | EV / Sales 2023 | 83x |
| Free-Float |
85.78% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0.02 |
| 3 years | 0 | | 78.96 |
| 5 years | 0 | | 410.4 |
| 10 years | 0 | | 21,983.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oliver Peoples
CEO | Chief Executive Officer | 68 | 16/10/2016 |
Charles Haaser
DFI | Director of Finance/CFO | 70 | 02/11/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Oliver Peoples
BRD | Director/Board Member | 68 | 06/07/2009 |
| Chairman | 69 | 07/11/2011 | |
Richard Hamilton
BRD | Director/Board Member | 63 | 01/03/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -4.99% | 0% | 293,477 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -99.33% | -100.00% | 73 | |
| -2.02% | -5.23% | -12.86% | -11.14% | 46.15B | |
| +2.79% | -5.01% | +17.18% | +26.18% | 32.5B | |
| +0.47% | -12.19% | +19.65% | +54.08% | 31.16B | |
| -2.25% | -2.42% | -5.92% | -20.53% | 29.96B | |
| -1.24% | -3.55% | +150.89% | +294.55% | 19.75B | |
| +1.39% | +3.06% | +58.83% | +111.91% | 14.57B | |
| -1.64% | -4.64% | +27.38% | +2.90% | 13.4B | |
| +0.26% | +4.17% | +44.47% | +134.63% | 13.32B | |
| -1.49% | -8.76% | +115.30% | +104.25% | 12.42B | |
| Average | -0.31% | -2.01% | +31.56% | +59.68% | 21.32B | |
| Weighted average by Cap. | -0.32% | -3.14% | +31.08% | +56.19% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 450K 388K 350K 336K 613K 41.36M 641K 4.14M 1.66M 19.83M 1.69M 1.65M 70.93M | 60K 51.73K 46.7K 44.81K 81.71K 5.51M 85.51K 552K 221K 2.64M 225K 220K 9.46M |
| Net income | -13.57M -11.7M -10.56M -10.13M -18.47M -1.25B -19.33M -125M -50.01M -598M -50.91M -49.83M -2.14B | -14.46M -12.46M -11.25M -10.8M -19.68M -1.33B -20.6M -133M -53.28M -637M -54.25M -53.09M -2.28B |
| Net Debt | -1.7M -1.46M -1.32M -1.27M -2.31M -156M -2.42M -15.61M -6.26M -74.79M -6.37M -6.23M -267M | 2.11M 1.82M 1.64M 1.58M 2.87M 194M 3.01M 19.41M 7.78M 92.99M 7.92M 7.75M 333M |
Employees
29
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/03/26 | - $ | - | 2 |
| 27/02/26 | - $ | - | 20 |
| 26/02/26 | - $ | - | 58 |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- YTENQ Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition